Topics

Cascade CGM 15-day Performance Assessment

2019-09-26 05:42:34 | BioPortfolio

Summary

To validate the feasibility of a 15-day wear period of the Cascade CGM system

Description

To assess a 15-day wear period for the Cascade CGM. This study includes ten subjects who will interface with the system and take finger stick BGM glucose values for calibration. The wear period includes four in-clinic days frequent blood draws and eleven at home days at a single testing site.

Study Design

Conditions

Continuous Glucose Monitoring

Intervention

Cascade Continuous Glucose Monitoring System

Status

Not yet recruiting

Source

WaveForm Technologies Inc.

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-09-26T05:42:34-0400

Clinical Trials [7941 Associated Clinical Trials listed on BioPortfolio]

Glucose Monitoring in Tissue Transfers

The purpose of this study is to determine if 1) a continuous glucose monitoring system can measure glucose levels in transferred tissue during reconstructive surgery, and 2) if glucose mea...

Evaluation of the Eversense Continuous Glucose Monitoring System in Type I Diabetic Youth

The purpose of this clinical investigation is to provide pilot clinical data to direct pivotal study development for the pediatric indication of the Senseonics Continuous Glucose Monitorin...

Continuous Glucose Monitoring (CGM) After Surgical Variations of the Roux-en-y Gastric Bypass

This study evaluates the difference in post prandial tissue glucose levels between two variation of Roux-en-Y Gastric bypass by continuous glucose monitoring.

Assessment of the Accuracy,Feasibility,Safety of Continuous Glucose Monitoring System

Real-time continuous glucose monitoring system (CGMS) has been attempted to be used in ICU, but its feasibility, accuracy and confounding factors are controversial.

Primary Care - Continuous Glucose Monitoring

Introduction and objective: The key to optimal diabetes management is tight glucose control. Hemoglobin A1c is the gold standard to assess glycemic control but in cases of unrecognized hyp...

PubMed Articles [17277 Associated PubMed Articles listed on BioPortfolio]

Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy.

Continuous glucose monitoring tends to replace capillary blood glucose (CBG) self-monitoring. Our aim was to determine the agreement between CBG and a flash glucose monitoring system (Flash-GMS) in tr...

Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.

In 2016 intermittently scanned continuous glucose monitoring (isCGM) became the first reimbursed CGM system in Belgium. Many children with type 1 diabetes (T1D) treated with multiple daily injections ...

Mussel-inspired enzyme immobilization and dual real-time compensation algorithms for durable and accurate continuous glucose monitoring.

Blood glucose sensing is very important for diabetic management. It is shifting towards a continuous glucose monitoring because such a system can alleviate patient suffering and provide a large number...

Reliability of real-time continuous glucose monitoring in infants.

Neonatal hypoglycemia is a common and treatable risk factor for neurological impairment. Real-time continuous glucose monitoring (RT-CGM) can show glucose concentrations in real time. Using an alarm o...

Continuous glucose monitoring in cystic fibrosis - A practical guide.

Our ability to monitor blood glucose levels has become increasingly accurate over the last few decades. Continuous glucose monitoring (CGM) technology now allows providers and patients the ability to ...

Medical and Biotech [MESH] Definitions

Continuous measurement of the movement and forces of blood in the CARDIOVASCULAR SYSTEM.

The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine.

Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.

Simultaneous and continuous monitoring of several parameters during sleep to study normal and abnormal sleep. The study includes monitoring of brain waves, to assess sleep stages, and other physiological variables such as breathing, eye movements, and blood oxygen levels which exhibit a disrupted pattern with sleep disturbances.

Hospital unit providing continuous monitoring of the patient following anesthesia.

More From BioPortfolio on "Cascade CGM 15-day Performance Assessment"

Quick Search

Searches Linking to this Trial